成人脊柱畸形手术中侧方椎间融合术的成本效益有限
该回顾性病例系列比较了多节段侧方椎间融合联合后路脊柱融合(L组,39例)与常规后路脊柱融合(P组,49例)治疗成人脊柱畸形的效用与成本效益,两组随访至少2年。两组健康相关生活质量改善相似且翻修率无显著差异,但L组手术时间更长、出血量更少,而初始手术直接成本和2年总住院成本均显著更高。
要点
- L组与P组在2年时SRS-22总分改善相似(3.86 vs 3.80,P=0.54)。
- L组手术时间更长(354 vs 268分钟,P<0.01),P组出血量更多(494 vs 678 mL,P=0.03)。
- L组初始手术直接成本及2年总住院成本均显著高于P组。
核心结论
- LIF联合PSF治疗ASD与传统PSF同样有效,但成本显著更高,因此有必要在不同ASD患者队列中进一步研究LIF的成本效益。
研究设计与样本
- 回顾性病例系列,比较88例手术治疗的ASD患者(L组n=39,P组n=49),来自多中心数据库,随访至少2年。
主要发现
- 矢状面脊柱序列在基线和术后2年两组间无显著差异。
- 手术时间L组更长(L vs P:354 vs 268分钟,P<0.01),出血量P组更多(L vs P:494 vs 678 mL,P=0.03)。
- 术后2年HRQoL改善相似(L vs P:SRS-22总分3.86 vs 3.80,P=0.54),翻修率相当(L vs P:18% vs 10%,P=0.29)。
- 初始手术总直接成本L组显著更高(65,937 vs 49,849 USD,P<0.01),主要由于手术室成本包括植入物成本(54,466 vs 41,328 USD,P<0.01)。
- 包括翻修手术在内的2年总住院成本L组也显著更高(70,847 vs 52,560 USD,P<0.01)。
关键数值与推荐
- L组与P组在2年时SRS-22总分分别为3.86 vs 3.80(P=0.54)。
- 翻修率L组18% vs P组10%(P=0.29)。
- 初始手术总直接成本L组65,937 USD vs P组49,849 USD(P<0.01)。
- 2年总住院成本L组70,847 USD vs P组52,560 USD(P<0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Retrospective case series. OBJECTIVE: The aim of this study was to compare the utility and cost-effectiveness of multilevel lateral interbody fusion (LIF) combined with posterior spinal fusion (PSF) (L group) and conventional PSF (with transforaminal lumbar interbody fusion) (P group) in adult spinal deformity (ASD) surgery. SUMMARY OF BACKGROUND DATA: The clinical and radiographic outcomes of multilevel LIF for ASD have been reported favorable; however, the cost benefit of LIF in conjunction with PSF is still controversial. METHODS: Retrospective comparisons of 88 surgically treated ASD patients with minimum 2-year follow-up from a multicenter database (L group [n = 39] and P group [n = 49]) were performed. Demographic and radiographic data, health-related quality of life (HRQoL), and the direct hospitalization cost for the initial surgery and 2-year total hospitalization cost were analyzed. RESULTS: Analyses of sagittal spinal alignment showed no significant difference between the two groups at baseline and 2 years post-operation. Surgical time was longer in the L group (L vs. P: 354 vs. 268 minutes, P < 0.01), whereas the amount of blood loss was greater in the P group (494 vs. 678 mL, P = 0.03). The HRQoL was improved similarly at 2 years post-operation (L vs. P: SRS-22 total score, 3.86 vs. 3.80, P = 0.54), with comparable revision rates (L vs. P: 18% vs. 10%, P = 0.29). The total direct cost of index surgery was significantly higher in the L group (65,937 vs. 49,849 USD, P < 0.01), which was mainly due to the operating room cost, including implant cost (54,466 vs. 41,328 USD, P < 0.01). In addition, the 2-year total hospitalization cost, including revision surgery, was also significantly higher in the L group (70,847 vs. 52,560 USD, P < 0.01). CONCLUSION: LIF with PSF is a similarly effective surgery for ASD when compared with conventional PSF. However, due to the significantly higher cost, additional studies on the cost-effectiveness of LIF in different ASD patient cohorts are warranted. LEVEL OF EVIDENCE: 3.
引用
- Yamamoto T, Yagi M, Suzuki S, et al. Limited Cost Benefit of Lateral Interbody Fusion for Adult Spinal Deformity Surgery. Spine (Phila Pa 1976). 2021. PMID: 32956251. doi:10.1097/BRS.0000000000003703
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。